Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cenavisa is an established Spanish veterinary pharmaceutical company founded in 1965 and headquartered in Reus, Spain. The company specializes in the research, development, manufacture, and commercialization of high-quality veterinary medicines, biocides, and nutritional solutions for livestock, poultry, and aquaculture. Its extensive product portfolio includes antimicrobials, antiparasitics, anti-inflammatories, and disinfectants, which are exported to over 60 countries across five continents. Operating under strict European GMP standards, Cenavisa is a key subsidiary of S.P. Veterinaria (Grupo SP), leveraging integrated R&D capabilities to support global animal health and welfare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cenavisa.